Please login to the form below

Not currently logged in
Email:
Password:

personalised treatments

This page shows the latest personalised treatments news and features for those working in and with pharma, biotech and healthcare.

Immuno-oncology, personalised medicine continues to drive pharma sector

Immuno-oncology, personalised medicine continues to drive pharma sector

Despite being the top trends affecting the industry this year, there has been a lot of scepticism surrounding the accessibility of novel I-O therapies and personalised treatments. ... Personalised medicines have been identified as key treatments by the

Latest news

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    Most recently, Japanese firms have led research on plasma-based treatments for COVID-19. ... Not only does this provide a set of challenges for the Japanese government and health system, but for pharmaceutical companies trying to develop new and

  • Unlocking the potential of precision medicine in oncology Unlocking the potential of precision medicine in oncology

    who have extremely limited options currently, while also developing treatments to bring practice changing results. ... This ongoing research will undoubtedly help us to better understand the development of prostate cancer at the molecular level, so that

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    Once only imaginable in science fiction, the latest applications include engineered skin tissue to treat burns victims, custom-grown bones for implants and joint replacements, personalised dietary treatments using gut bacteria ... Regenerative medicine

  • Cannes Lions Healthcare Agency of the Year – championing change and demanding more… Cannes Lions Healthcare Agency of the Year – championing change and demanding more…

    AI and machine learning are revolutionising how we understand and use that data, helping us to develop new, more personalised treatments more quickly and more cheaply than we ever thought possible. ... But the reality of the best and most advanced

  • Reactivating drug research programmes Reactivating drug research programmes

    The actual number of drug trials that are abandoned each year before treatments reach the marketplace is unknown, at least at a global level. ... However, as drugs like Herceptin have shown, as long as there is a high degree of efficacy in a small group

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Horizon adds AZ’s Galbraith to board Horizon adds AZ’s Galbraith to board

    Galbraith is senior VP and head of oncology innovative medicines at AZ and knows Horizon well thanks to a collaboration between the two companies on personalised cancer treatments.

  • Horizon appoints board chair Horizon appoints board chair

    These growth prospects include a partnership with AstraZeneca to research personalised treatments in oncology.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...